ArticleDiabetes, metabolic syndrome and obesity : targets and therapy2025

Circulating Interleukin-22 Is a Biomarker for Newly Diagnosed Type 2 Diabetes Mellitus and Associated with Hypoglycemic Effect of Sitagliptin.

Peiye Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.